Cite
Biechele G, Blume T, Deussing M, et al. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation. Theranostics. 2021;11(18):8964-8976doi: 10.7150/thno.64022.
Biechele, G., Blume, T., Deussing, M., Zott, B., Shi, Y., Xiang, X., Franzmeier, N., Kleinberger, G., Peters, F., Ochs, K., Focke, C., Sacher, C., Wind, K., Schmidt, C., Lindner, S., Gildehaus, F. J., Eckenweber, F., Beyer, L., von Ungern-Sternberg, B., Bartenstein, P., Baumann, K., Dorostkar, M. M., Rominger, A., Cumming, P., Willem, M., Adelsberger, H., Herms, J., & Brendel, M. (2021). Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation. Theranostics, 11(18), 8964-8976. https://doi.org/10.7150/thno.64022
Biechele, Gloria, et al. "Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation." Theranostics vol. 11,18 (2021): 8964-8976. doi: https://doi.org/10.7150/thno.64022
Biechele G, Blume T, Deussing M, Zott B, Shi Y, Xiang X, Franzmeier N, Kleinberger G, Peters F, Ochs K, Focke C, Sacher C, Wind K, Schmidt C, Lindner S, Gildehaus FJ, Eckenweber F, Beyer L, von Ungern-Sternberg B, Bartenstein P, Baumann K, Dorostkar MM, Rominger A, Cumming P, Willem M, Adelsberger H, Herms J, Brendel M. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation. Theranostics. 2021 Aug 19;11(18):8964-8976. doi: 10.7150/thno.64022. eCollection 2021. PMID: 34522221; PMCID: PMC8419052.
Copy
Download .nbib